Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating both early and late onset alopecia areata.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Effective treatment for UFT overdose includes antibiotics and G-CSF, with bone marrow biopsy and transfusion as backup options.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Adjusting minoxidil dosage may be safer than using bicalutamide for hair loss in women.

Fremanezumab effectively reduces migraines and improves quality of life with mild side effects.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Zebularine improved skin structure but delayed wound healing in diabetic mice.

2% Minoxidil does not prevent hair loss during chemotherapy.

Controlled microflora in animals delays immune cell maturation and affects immunity.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

Live vaccines can be safely given to infants with a FOXN1 variant if their immune function improves over time.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Talquetamab may cause hair loss and skin issues.

Type B Insulin Resistance Syndrome is rare, linked to lupus, and hard to treat due to severe insulin resistance.

Noggin promotes skin tumors by activating certain cell signaling pathways.